Tiger Brokers

BRIEF-Rallybio Corporation And Candid Therapeutics Announce Merger Agreement

Reuters
Mar 02
BRIEF-Rallybio Corporation And Candid <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announce Merger Agreement

March 2 (Reuters) - Rallybio Corp RLYB.O:

  • RALLYBIO CORPORATION AND CANDID THERAPEUTICS ANNOUNCE MERGER AGREEMENT

  • RALLYBIO CORP - OVER $505 MILLION FINANCING COMMITTED BY INVESTORS

  • RALLYBIO CORP: COMBINED COMPANY'S CASH BALANCE AT CLOSING IS EXPECTED TO FUND OPERATIONS THROUGH 2030

  • RALLYBIO CORP: PRE-TRANSACTION RALLYBIO EQUITYHOLDERS ARE EXPECTED TO OWN APPROXIMATELY 3.65% OF COMBINED CO

  • RALLYBIO CORP - KEN SONG TO LEAD COMBINED COMPANY AS CEO

  • RALLYBIO CORP - PRO-FORMA CASH OF ABOUT $700 MILLION EXPECTED AT CLOSING

Source text: ID:nBw1f6M4wa

Further company coverage: RLYB.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10